Meeting
2024 ASCO Gastrointestinal Cancers Symposium
Prognosis and clinical and molecular characteristics of patients with brain metastasis secondary to pancreatic ductal adenocarcinoma.
Authors
Mahmoud M.G. Yousef
The University of Texas MD Anderson Cancer Center, Houston, TX
Mahmoud M.G. Yousef , Abdelrahman M.G. Yousef , Mark W. Hurd , Ethan B. Ludmir , Eugene Jon Koay , Rebecca A Snyder , Huamin Wang , Ching-Wei D. Tzeng , Anirban Maitra , Shubham Pant , James C. Yao , John Paul Y.C. Shen , Dan Zhao
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Track
Pancreatic Cancer,Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Small Bowel Cancer
Sub Track
Patient-Reported Outcomes and Real-World Evidence
Citation
J Clin Oncol 42, 2024 (suppl 3; abstr 635)
DOI
10.1200/JCO.2024.42.3_suppl.635
Abstract #
635
Poster Bd #
K4
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Mutational landscape of pancreatic adenocarcinoma identified by prospective clinical sequencing in a nationwide cancer network.
First Author: Katherine E Poruk
Poster
2022 ASCO Annual Meeting
Evaluation of stage IV pancreatic adenocarcinomas based on mutational profiling of tumors.
First Author: Katherine E Poruk
Poster
2019 Gastrointestinal Cancers Symposium
KRAS and TP53 status as a predictor of survival in patients with resected pancreatic ductal adenocarcinoma.
First Author: Caitlin A McIntyre
Poster
2019 Gastrointestinal Cancers Symposium
The impact of CDKN2A mutations on overall survival in pancreatic adenocarcinoma.
First Author: Allison Doyle